Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy
- 31 July 2007
- journal article
- Published by Elsevier in Infection, Genetics and Evolution
- Vol. 7 (4) , 476-483
- https://doi.org/10.1016/j.meegid.2007.02.001
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The Hill–Robertson Effect and the Evolution of RecombinationGenetics, 2006
- Comment on "Evidence for Positive Epistasis in HIV-1"Science, 2006
- Stochastic Interplay between Mutation and Recombination during the Acquisition of Drug Resistance Mutations in Human Immunodeficiency Virus Type 1Journal of Virology, 2005
- HIV recombination: what is the impact on antiretroviral therapy?Journal of The Royal Society Interface, 2005
- Evolution of Human Immunodeficiency Virus Under Selection and Weak RecombinationGenetics, 2005
- Pervasive Genomic Recombination of HIV-1 in VivoGenetics, 2004
- Transition between Stochastic Evolution and Deterministic Evolution in the Presence of Selection: General Theory and Application to VirologyMicrobiology and Molecular Biology Reviews, 2001
- Possible involvement of cell fusion and viral recombination in generation of human immunodeficiency virus variants that display dual resistance to AZT and 3TCJournal of General Virology, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995